Preliminary experience with chemotherapy in advanced salivary gland neoplasms

C. P. Belani, Mario Eisenberger, W. C. Gray

Research output: Contribution to journalArticle

Abstract

Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites. Side effects were acceptable. All patients had moderate nausea and some degree of vomiting, which were adequately controlled by antiemetics. These results are preliminary but when considered with other reported trials using the same combination suggest an active treatment program for advanced neoplasms of the salivary glands.

Original languageEnglish (US)
Pages (from-to)197-202
Number of pages6
JournalMedical and Pediatric Oncology
Volume16
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Salivary Gland Neoplasms
Drug Therapy
Antiemetics
Salivary Glands
Doxorubicin
Cyclophosphamide
Nausea
Cisplatin
Vomiting
Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Preliminary experience with chemotherapy in advanced salivary gland neoplasms. / Belani, C. P.; Eisenberger, Mario; Gray, W. C.

In: Medical and Pediatric Oncology, Vol. 16, No. 3, 1988, p. 197-202.

Research output: Contribution to journalArticle

@article{d840b4f7f3ce4cfbb60c882bd27d8dd0,
title = "Preliminary experience with chemotherapy in advanced salivary gland neoplasms",
abstract = "Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites. Side effects were acceptable. All patients had moderate nausea and some degree of vomiting, which were adequately controlled by antiemetics. These results are preliminary but when considered with other reported trials using the same combination suggest an active treatment program for advanced neoplasms of the salivary glands.",
author = "Belani, {C. P.} and Mario Eisenberger and Gray, {W. C.}",
year = "1988",
language = "English (US)",
volume = "16",
pages = "197--202",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Preliminary experience with chemotherapy in advanced salivary gland neoplasms

AU - Belani, C. P.

AU - Eisenberger, Mario

AU - Gray, W. C.

PY - 1988

Y1 - 1988

N2 - Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites. Side effects were acceptable. All patients had moderate nausea and some degree of vomiting, which were adequately controlled by antiemetics. These results are preliminary but when considered with other reported trials using the same combination suggest an active treatment program for advanced neoplasms of the salivary glands.

AB - Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites. Side effects were acceptable. All patients had moderate nausea and some degree of vomiting, which were adequately controlled by antiemetics. These results are preliminary but when considered with other reported trials using the same combination suggest an active treatment program for advanced neoplasms of the salivary glands.

UR - http://www.scopus.com/inward/record.url?scp=0023751229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023751229&partnerID=8YFLogxK

M3 - Article

C2 - 2837623

AN - SCOPUS:0023751229

VL - 16

SP - 197

EP - 202

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -